Naftopidil

DB12092InvestigationalSmall molecule

Naftopidil has been investigated for the treatment of Disorder of Urinary Stent.

Chemical structure of Naftopidil
Mechanism
Curator reviewed
Formula / weight
C24H28N2O3 · 392.499 g/mol (avg)

Resolves to

Compound
UNIIR9PHW59SFNCAS57149-07-2ChEMBLCHEMBL142635ChEBI31891PubChem4418
Structure
InChIKeyHRRBJVNMSRJFHQ-UHFFFAOYSA-NSMILESCOC1=CC=CC=C1N1CCN(CC(O)COC2=CC=CC3=CC=CC=C23)CC1
Targets
P25100ADRA1DP35348ADRA1A

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,359Drug interactionsStructured to mechanism, not free text
Sign in
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Naftopidil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In